Immunomodulatory drugs:These drugs are the workhorses of multiple myeloma treatment. They work on your immune system. Some turn on certain immune cells, and others stop the signals that tell cancer cells to grow so they kill myeloma cells. Proteasome inhibitors:Proteasomes are protein complexes tha...
CA Cancer J Clin. 2016;66(1):7-30.PubMedGoogle ScholarCrossref 2. Surveillance, Epidemiology, and End Results. Cancer Stat Facts: Myeloma. 2014. https://seer.cancer.gov/statfacts/html/mulmy.html. Accessed February 22, 2018. 3. Howlader N, Noone A, Krapcho M, et al. SEER Cancer St...
Worldwide, approximately 159,985 new cases of MM are diagnosed representing 0.9% of all cancer diagnoses and 106,105 patients will die from MM accounting for 1.1% of all cancer deaths per year. Despite significant advances in the MM treatment the mortality rates are still high. The presented ...
Multiple myeloma (MM) is an aggressive and currently incurable blood cancer that affects plasma cells made in the bone marrow. Healthy plasma cells make antibodies that help the body fight infection.1 MM is the second most common type of blood cancer, with over 50,000 new cases ...
Essential facts Myeloma, also known as multiple myeloma, is a form of cancer that arises from plasma cells, which are a type of white blood cell made in the bone marrow. It affects multiple areas where bone marrow is found - including the spine, skull, pelvis, ribs, arms and legs. Whil...
Myeloma is a form of cancer that rises from white blood cells. The disease usually causes malignant cells to grow within bone marrow. This book draws upon the most current medical research to explain the biology of this form of cancer, how it is diagnosed, and how it is treated. Myeloma ...
Effects of disease progression on healthcare resource utilization (HRU) and costs among multiple myeloma (MM) patients with ≥1 line of therapy (LOT) who received their first stem cell transplant (SCT) within 1 year of initial MM diagnosis were estimated
et al. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat. Med. 24, 1867–1876 (2018). Article CAS PubMed Google Scholar Jang, J. S. et al. Molecular signatures of multiple myeloma progression through single cell RNA-seq. Blood Cancer J. 9, ...
http://seer.cancer.gov/statfacts/html/mulmy.html. Accessed 3 Feb 2021. Landgren O, Weiss B. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia. 2009;23:1691–7. https://doi....
Immunotherapy of Lymphoma and Myeloma: Facts and Hopes MJ Pianko,AJ Moskowitz,AM Lesokhin - Clin Cancer Res 被引量: 0发表: 2017年 Facts and Hopes in Immunotherapy of Lymphoma and Myeloma Immune checkpoint blockade has driven a revolution in modern oncology, and robust drug development of immune...